Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Clinical Microbiology
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1428827
This article is part of the Research Topic Pathogenesis and Antimicrobial Resistance in Gram-negative Bacteria View all 6 articles

Recombinase-Aided Amplification Assay for Rapid Detection of Imipenem-resistant Pseudomonas aeruginosa (IRPA) and Rifampinresistant Pseudomonas aeruginosa (RRPA)

Provisionally accepted
Zhou Yao Zhou Yao 1shi r. qing shi r. qing 1mu liang mu liang 2lin l. tian lin l. tian 1zhou m. shan zhou m. shan 1lv w. han lv w. han 1Yaodong Chen Yaodong Chen 1*
  • 1 Northwest University, Xi'an, China
  • 2 Ultrasonic Diagnosis Center, Shaanxi Provincial People’s Hospital, Xi'an, China

The final, formatted version of the article will be published soon.

    The indiscriminate use of antibiotics has resulted in a growing resistance to drugs in Pseudomonas aeruginosa. The identification of antibiotic resistance genes holds considerable clinical significance for prompt diagnosis. In this study, we established and optimized a Recombinase-Aided Amplification (RAA) assay to detect two genes associated with drug resistance, oprD and arr, in 101 clinically collected P. aeruginosa isolates. Through screening for the detection or absence of oprD and arr, the results showed that there were 52 Imipenem-resistant P. aeruginosa (IRPA) strains and 23 Rifampin-resistant P. aeruginosa (RRPA) strains. This method demonstrated excellent detection performance even when the sample concentration is 10 copies/μL at isothermal conditions and the results could be obtained within 20 minutes. The detection results were in accordance with the results of conventional PCR and Real-time PCR. The detection outcomes of the arr gene were consistently with the resistance spectrum. However, the antimicrobial susceptibility results revealed that 65 strains were resistant to imipenem, while 49 strains sensitive to imipenem with oprD were identified. This discrepancy could be attributed to genetic mutations. In summary, the RAA has higher sensitivity, shorter time, and lower-cost instrument requirements than traditional detection methods.In addition, to analyze the epidemiological characteristics of the aforementioned drug-resistant strains, we conducted Multilocus Sequence Typing (MLST), virulence gene, and antimicrobial susceptibility testing. MLST analysis showed a strong correlation between the sequence types ST-1639, ST-639, ST-184 and IRPA, while ST-261 was the main subtype of RRPA. It was observed that these drug-resistant strains all possess five or more virulence genes, among which exoS and exoU do not coexist, and they are all multidrug-resistant strains. The non-coexistence of exoU and exoS in P.aeruginosa is related to various factors including bacterial regulatory mechanisms and pathogenic mechanisms. This indicates that the relationship between the presence of virulence genes and the severity of patient infection is worthy of attention.In conclusion, we have developed a rapid and efficient RAA (Recombinase-Aided Amplification) detection method that offers significant advantages in terms of speed, simplicity, and costeffectiveness (especially in time and equipment aspect). This novel approach is designed to meet the demands of clinical diagnostics.

    Keywords: Pseudomonas aeruginosa, Recombinase-aided amplification, Rapid detection, Antimicrobial susceptibility testing, ARR, OprD

    Received: 07 May 2024; Accepted: 24 Jul 2024.

    Copyright: © 2024 Yao, qing, liang, tian, shan, han and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yaodong Chen, Northwest University, Xi'an, 710075, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.